Nasopharyngeal Cancer Market

Nasopharyngeal Cancer Market by Types (Non-keratinizing undifferentiated carcinoma, Non-keratinizing differentiated carcinoma, Keratinizing squamous cell carcinoma), Therapies (Chemotherapy, Immunotherapy, Radiation Therapy, and Others), End Users (Hospitals, Clinics, Cancer Treatment & Rehabilitation Centers, Ambulatory Surgery Centers, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1100
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 198
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global nasopharyngeal cancer market size is projected to expand at a considerable CAGR of 2.4% during the forecast period, 2021–2028. The growth of the market is attributed to the Growing cases of cancer, increasing geriatric population, and advancements in medical technologies for diagnostic and prevention of cancers.
 

Nasopharyngeal Cancer Market Key Takeaways


Nasopharyngeal cancer is a type of head and neck cancer which originates from upper part of the throat and behind nose and near the base of the skull know as nasopharynx. Cancer is a disease when some of the body’s cells grow uncontrollably and spread to other parts of the body. Nasopharynx is the upper part of the throat that lies behind the nose, it is a box-like chamber and lies just above the soft part of the rood of the mouth and just behind the nasal passages. It is diagnosed as a chronic disorder.

Generally nasopharyngeal cancers are mostly nasopharyngeal carcinoma (NPC) which is by far the most common cancer in the nasopharynx. Carcinoma is cancer that originates from the cells that line the internal and external surfaces of the body called epithelial cells. Treatment begins with diagnosis of the cancer with tests and procedures such as physical exam and patient history, neurological exam, biopsy, upper endoscopy, MRI (magnetic resonance imaging), and CT scan, among others.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing cases of cancers among the population worldwide due to growth in tobacco and alcohol consumption is anticipated to push the market expansion in the coming years.
  • Rising burden of disease, growing awareness towards diagnosis and treatment, and rapid adoption of modern healthcare medical devices are major factors spurring the market growth during the forecast period.
  • High price treatment and therapeutic procedures such as diagnosis, surgeries, chemotherapy, and radiation therapy are expected to hamper the market expansion.
  • Lack of medical insurance among majority of population in developing and underdeveloped regions across the globe and high prices of drugs adding financial burden of the treatment are some of the major challenges that hinder the market growth in the coming years.
  • R&D investment and technological advancements in healthcare devices particularly in diagnostic and prevention are anticipated to offer significant opportunities for the market players.

Scope of the Report

The report on the global nasopharyngeal cancer market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Nasopharyngeal Cancer Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Types (Non-keratinizing undifferentiated carcinoma, Non-keratinizing differentiated carcinoma, Keratinizing squamous cell carcinoma), Therapies (Chemotherapy, Immunotherapy, Radiation Therapy, and Others), End Users (Hospitals, Clinics, Cancer Treatment & Rehabilitation Centers, Ambulatory Surgery Centers, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Biocon Limited, Bristol Myers Squibb,Eli Lilly and Company, Cyclacel Pharmaceuticals, Sanofi S.A., Celgene Corporation, BioDiem Ltd, Merck & Co., Inc.

 

Market Segment Insights

Non-Keratinizing undifferentiated carcinoma segment is projected to account for a major market share
Based on types, the nasopharyngeal cancer market divided into non-keratinizing undifferentiated carcinoma, non-keratinizing differentiated carcinoma, keratinizing squamous cell carcinoma. Non-Keratinizing undifferentiated carcinoma segment is projected to account for a major market share. It is the most common type of NPC among the three, they also tend to respond better to treatment depending upon the stage of cancer or how far it is spread.
 

Nasopharyngeal Cancer Market By Types


Radiation therapy segment is expected to represent significant market share
Based on therapies, the nasopharyngeal cancer market is segmented into chemotherapy, immunotherapy, radiation therapy, and others. Radiation therapy segment is expected to represent significant market share. The treatment procedure is at an early clinical phase with positive outlook estimated due to which commercial applications on a large scale is projected during the end of forecast period. In this treatment procedure, a person receives radiation therapy followed by use of drugs to destroy the cancer cells.

On the other hand, chemotherapy is projected to grow at a considerable rate during the forecast period. The segment growth is attributed to the recent success in adoption of radiation and chemotherapy at the same time. Chemotherapy makes cancer cells more sensitive to radiation therapy, aiding in destroying more of the tumor, it also helps eradicate cancer that may have spread that may spread to other parts of the body.

Hospital segment is anticipated to exhibit a robust CAGR
In terms of end users, the nasopharyngeal cancer market is segregated into hospitals, clinics, cancer treatment & rehabilitation centers, ambulatory surgery centers, and others. Hospital segment is anticipated to exhibit a robust CAGR due to rapid adoption of modern cancer diagnostic and prevention technologies, increasing medical expenditure in the emerging markets, and growing healthcare awareness.

North America is expected to dominate the market
On the basis of regions, the nasopharyngeal cancer market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market during the forecast period. The regional market growth can be attributed to increasing research and development activities by key market players in the region to develop better treatment procedures. However, Asia Pacific is expected to exhibit a rapid growth rate in the coming years owing to increasing cases of cancers in the head and neck areas. Market players are investing heavily in the developing economies across the regions which is expected to drive the market expansion during the forecast period.
 

Nasopharyngeal Cancer Market By Regions

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nasopharyngeal Cance Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Nasopharyngeal Cance Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Nasopharyngeal Cance Market - Supply Chain
  4.5. Global Nasopharyngeal Cance Market Forecast
     4.5.1. Nasopharyngeal Cance Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Nasopharyngeal Cance Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Nasopharyngeal Cance Market Absolute $ Opportunity
5. Global Nasopharyngeal Cance Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Nasopharyngeal Cance Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Nasopharyngeal Cance Demand Share Forecast, 2019-2026
6. North America Nasopharyngeal Cance Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Nasopharyngeal Cance Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Nasopharyngeal Cance Demand Share Forecast, 2019-2026
7. Latin America Nasopharyngeal Cance Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Nasopharyngeal Cance Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Nasopharyngeal Cance Demand Share Forecast, 2019-2026
8. Europe Nasopharyngeal Cance Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Nasopharyngeal Cance Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Nasopharyngeal Cance Demand Share Forecast, 2019-2026
9. Asia Pacific Nasopharyngeal Cance Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Nasopharyngeal Cance Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Nasopharyngeal Cance Demand Share Forecast, 2019-2026
10. Middle East & Africa Nasopharyngeal Cance Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Nasopharyngeal Cance Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Nasopharyngeal Cance Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Nasopharyngeal Cance Market: Market Share Analysis
  11.2. Nasopharyngeal Cance Distributors and Customers
  11.3. Nasopharyngeal Cance Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Biocon Limited
     11.4.2. Bristol Myers Squibb
     11.4.3. Eli Lilly and Company
     11.4.4. Cyclacel Pharmaceuticals
     11.4.5. Sanofi S.A.
     11.4.6. Celgene Corporation
     11.4.7. BioDiem Ltd
     11.4.8. Merck & Co., Inc.

Segments Covered in the Report

Types

  • Non-keratinizing undifferentiated carcinoma
  • Non-keratinizing differentiated carcinoma
  • Keratinizing squamous cell carcinoma

Therapies

  • Chemotherapy
  • Immunotherapy
  • Radiation Therapy
  • Others

End Users

  • Hospitals
  • Clinics
  • Cancer Treatment & Rehabilitation Centers
  • Ambulatory Surgery Centers
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Biocon Limited
  • Bristol Myers Squibb
  • Eli Lilly and Company
  • Cyclacel Pharmaceuticals
  • Sanofi S.A.
  • Celgene Corporation
  • BioDiem Ltd
  • Merck & Co., Inc.

Key players competing in the nasopharyngeal cancer market include Biocon Limited, Bristol Myers Squibb,Eli Lilly and Company, Cyclacel Pharmaceuticals, Sanofi S.A., Celgene Corporation, BioDiem Ltd, Merck & Co., Inc.
 

Nasopharyngeal Cancer Market By Key Players

Buy Report